These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8883150

  • 1. Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID mice.
    Koup RA, Safrit JT, Weir R, Gauduin MC.
    Semin Immunol; 1996 Aug; 8(4):263-8. PubMed ID: 8883150
    [Abstract] [Full Text] [Related]

  • 2. Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism.
    van Kuyk R, Torbett BE, Gulizia RJ, Leath S, Mosier DE, Koenig S.
    J Immunol; 1994 Nov 15; 153(10):4826-33. PubMed ID: 7963548
    [Abstract] [Full Text] [Related]

  • 3. In SCID-hu mice, passive transfer of a humanized antibody prevents infection and atrophic change of medulla in human thymic implant due to intravenous inoculation of primary HIV-1 isolate.
    Okamoto Y, Eda Y, Ogura A, Shibata S, Amagai T, Katsura Y, Asano T, Kimachi K, Makizumi K, Honda M.
    J Immunol; 1998 Jan 01; 160(1):69-76. PubMed ID: 9551957
    [Abstract] [Full Text] [Related]

  • 4. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C, Spada M, Santini SM, Racca S, Dorigatti F, Poli G, Belardelli F, Alfano M.
    Int Immunol; 2005 Apr 01; 17(4):469-75. PubMed ID: 15746245
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.
    Okuma K, Tanaka R, Ogura T, Ito M, Kumakura S, Yanaka M, Nishizawa M, Sugiura W, Yamamoto N, Tanaka Y.
    J Infect Dis; 2008 Jan 01; 197(1):134-41. PubMed ID: 18171296
    [Abstract] [Full Text] [Related]

  • 6. SCID-hu mice: a model for studying disseminated HIV infection.
    Goldstein H, Pettoello-Mantovani M, Katopodis NF, Kim A, Yurasov S, Kollmann TR.
    Semin Immunol; 1996 Aug 01; 8(4):223-31. PubMed ID: 8883145
    [Abstract] [Full Text] [Related]

  • 7. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C, Santini SM, Proietti E, Rizza P, Logozzi M, Spada M, Parlato S, Fais S, Pitha PM, Belardelli F.
    Virology; 1999 Oct 10; 263(1):78-88. PubMed ID: 10544084
    [Abstract] [Full Text] [Related]

  • 8. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
    Lapenta C, Santini SM, Logozzi M, Spada M, Andreotti M, Di Pucchio T, Parlato S, Belardelli F.
    J Exp Med; 2003 Jul 21; 198(2):361-7. PubMed ID: 12874266
    [Abstract] [Full Text] [Related]

  • 9. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M, Brown SA, Tutt LM, Tan J, Seehafer DL, Harris JP, Xun CQ, Thompson JS.
    Clin Transplant; 1997 Oct 21; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [Abstract] [Full Text] [Related]

  • 10. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.
    Gauduin MC, Parren PW, Weir R, Barbas CF, Burton DR, Koup RA.
    Nat Med; 1997 Dec 21; 3(12):1389-93. PubMed ID: 9396610
    [Abstract] [Full Text] [Related]

  • 11. hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120.
    Safrit JT, Fung MS, Andrews CA, Braun DG, Sun WN, Chang TW, Koup RA.
    AIDS; 1993 Jan 21; 7(1):15-21. PubMed ID: 7680205
    [Abstract] [Full Text] [Related]

  • 12. Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin.
    Delhem N, Hadida F, Gorochov G, Carpentier F, de Cavel JP, Andréani JF, Autran B, Cesbron JY.
    J Immunol; 1998 Aug 15; 161(4):2060-9. PubMed ID: 9712080
    [Abstract] [Full Text] [Related]

  • 13. Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.
    Parren PW, Ditzel HJ, Gulizia RJ, Binley JM, Barbas CF, Burton DR, Mosier DE.
    AIDS; 1995 Jun 15; 9(6):F1-6. PubMed ID: 7662189
    [Abstract] [Full Text] [Related]

  • 14. Viral pathogenesis in hu-PBL-SCID mice.
    Mosier DE.
    Semin Immunol; 1996 Aug 15; 8(4):255-62. PubMed ID: 8883149
    [Abstract] [Full Text] [Related]

  • 15. Involvement of the complement system in antibody-mediated post-exposure protection against human immunodeficiency virus type 1.
    Gauduin MC, Weir R, Fung MS, Koup RA.
    AIDS Res Hum Retroviruses; 1998 Feb 10; 14(3):205-11. PubMed ID: 9491910
    [Abstract] [Full Text] [Related]

  • 16. SCID-hu-PBL: a model for making human antibodies?
    Ifversen P, Borrebaeck CA.
    Semin Immunol; 1996 Aug 10; 8(4):243-8. PubMed ID: 8883147
    [Abstract] [Full Text] [Related]

  • 17. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A, Tanaka R, Kodama A, Yamamoto N, Ansari AA, Tanaka Y.
    Clin Dev Immunol; 2005 Dec 10; 12(4):235-42. PubMed ID: 16584108
    [Abstract] [Full Text] [Related]

  • 18. HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model.
    Taggart BR, Harrington P, Hollingshead M.
    Antiviral Res; 2004 Jul 10; 63(1):1-6. PubMed ID: 15196814
    [Abstract] [Full Text] [Related]

  • 19. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH, Bühler B, Steinberger P, Tschan MP, Barbas CF, Torbett BE.
    Gene Ther; 2006 Oct 10; 13(20):1480-92. PubMed ID: 16738691
    [Abstract] [Full Text] [Related]

  • 20. The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS.
    Jamieson BD, Aldrovandi GM, Zack JA.
    Semin Immunol; 1996 Aug 10; 8(4):215-21. PubMed ID: 8883144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.